TABLE 1.
Summary of 226 Salmonella serotype Typhimurium isolates analyzed by the MDU
| Phage type | R typea | IP type | Source
|
No. of isolates (subtotal) | ||
|---|---|---|---|---|---|---|
| H | V | F | ||||
| 104 | ACSSuT | I | 107 | 47 | 8 | 162 |
| 104 | ACSSuTTp | I | 2 | 2 | 0 | 4 |
| 104 | ACSSuTN | I | 1 | 0 | 0 | 1 |
| 104b | ACSSuTK | I | 0 | 0 | 3 | 3 |
| 104b | ACSSuTTp | I | 1 | 2 | 0 | 3 |
| 104 | SSu | VII | 8 | 0 | 0 | 8 |
| 104 | ASu | III | 0 | 0 | 1 | 1 |
| U302 | ACSSuTTp | I | 0 | 1 | 0 | 1 (183) |
| 193 | ASSuTTp | II | 0 | 0 | 1 | 1 |
| 193 | ASSuTN | IV | 0 | 0 | 1 | 1 |
| 193 | ASSuT | IV | 1 | 3 | 2 | 6 |
| 193 | SuTTp | IV | 0 | 1 | 0 | 1 |
| 193 | ASuTTp | IV | 0 | 1 | 0 | 1 |
| 193 | SSuT | IV | 0 | 1 | 0 | 1 (11) |
| 195 | T | IV | 5 | 0 | 0 | 5 |
| 195 | SuTTp | IV | 0 | 1 | 0 | 1 |
| 195 | STp | IV | 0 | 0 | 1 | 1 |
| 195 | SuTp | IV | 0 | 0 | 1 | 1 |
| 195 | ASSuT | VI | 1 | 0 | 0 | 1 |
| 195 | ASSuT | IV | 2 | 0 | 0 | 2 |
| 195 | Sensitive | IV | 0 | 1 | 0 | 1 (12) |
| 204a | ASSuT | none | 0 | 0 | 2 | 2 (2) |
| 208 | T | IV | 0 | 3 | 0 | 3 |
| 208 | SuTTp | IV | 0 | 2 | 0 | 2 (5) |
| 170a | SuTTp | IV | 0 | 3 | 0 | 3 |
| 170a | ASSuTTp | II | 0 | 1 | 0 | 1 (4) |
| 15a | SuTTp | IV | 0 | 0 | 1 | 1 |
| 15a | T | IV | 1 | 0 | 0 | 1 (2) |
| NT | SuTp | V | 0 | 0 | 1 | 1 |
| NT | SuTp | IV | 1 | 0 | 0 | 1 |
| NT | ACSSuT | I | 2 | 0 | 0 | 2 |
| NT | Sensitive | IV | 1 | 0 | 0 | 1 |
| NT | Sensitive | V | 0 | 0 | 1 | 1 |
| NT | S | V | 0 | 1 | 0 | 1 (7) |
a
R type, antimicrobial resistance pattern; A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfonamide; T, tetracycline; Tp, trimethoprim; N, nalidixic acid; K, kanamycin.